ClinicalTrials.gg
CompletedNCT07283783Updated Oct 13, 2026

INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients

An interventional study of Wellness Program in Surgery, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-13.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 13, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Not applicable
Ages
60 Years and older
Sex
All
01

Study summary

In this study, the investigators will evaluate the feasibility of the Wellness Program, including patient recruitment, screening and outcome measures, and feasibility of adapting the intervention with older Black surgical patients who endorse clinically significant symptoms of depression and/or anxiety.

02

Conditions studied

  • Surgery

Browse trials for

Keywords

  • Perioperative Care
  • Minority Mental Health
  • Anxiety
  • Depression
  • Polypharmacy
  • Behavioral Treatment
  • Medication Counseling
  • Coordination
03

In context

Anxiety Disorders Unverified

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

This study's enrollment of 27 is below the median of 80 across 6,103 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Washington University School of Medicine is the lead sponsor of 1,806 studies on the registry; 271 are open to participants now.

Of its 329 completed or terminated interventional studies of FDA-regulated products, 216 (66%) have results posted.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥60 years
  • Scheduled surgical procedure at BJH or BJWCH (oncologic, cardiac; orthopedic)
  • depression or anxiety symptoms screened by the PHQ-ADS (Patient Health Questionnaire Anxiety and Depression Scale) ≥10
  • Black or African American.

Exclusion criteria

Exclusion Criteria Patients:

  • Inability to provide ;
  • Severe cognitive impairment screened by the SBT (Short Blessed Test) ≥10
  • Acutely suicidal
  • Considered ineligible per the discretion of the surgeon or study PI
  • Considered ineligible per the discretion of the surgeon or study PI

Caregiver participants:

If patients identify a caregiver that the patient would like to include in their Wellness Program, the caregiver will be invited to consent. Patients will provide contact information for their caregiver.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Wellness Program for Perioperative Mental Health

    Enrolled participants will participate in the study for approximately 3 months after surgery. The participants will complete questionnaires at baseline, 1 month after surgery, and 3 months after surgery. The Wellness Program will consist of Cognitive Behavioral Therapy (CBT) and medication optimization.

    Behavioral: Wellness Program

Interventions

  • BehavioralWellness Program

    The BCBT intervention consists of 8 to 10 structured sessions delivered remotely via phone or Zoom, beginning in the preoperative period and continuing for approximately three months after surgery. The interventionist will offer a protocolized review of current medications with feedback as appropriate, under guidance by the study psychiatrist. As additional optional components of the Wellness Program, the study team will also offer faith-based counseling as well as the option to involve family and friends as active or passive participants in the program.

06

What researchers measure

Primary outcomes

  1. Reach of the study as measured by number of patients who agree to participate in the study out of total eligible to participate

    Time frame: Through completion of enrollment for all participants (estimated to be 9 months, time for participant 1 day)

  2. Reach of the intervention as measured by number of patients who completed the intervention out of patients who agreed to participate in the study

    Time frame: Through completion of follow-up for all participants (estimated to be 12 months, time for participant 3 months)

Secondary outcomes

  1. Percentage of instrument or data fields completed for Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)

    Time frame: Baseline, 1 month after surgery, and 3 months after surgery

07

Study locations

1 site
  • Washington University School of Medicine
    St Louis, Missouri 63110, United States
08

References and documents

Individual participant data

Plan to share: Yes — Individual participant data collected during the trial, after deidentification, will be available, upon request. In addition, the study protocol will be available upon request.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Immediately following publication. No end date.

Access criteria: Researchers must provide a methodologically sound proposal that meets the approval of the author. Proposals should be directed to joannaa@wustl.edu. To gain access, data requestors will need to sign a data access agreement. Data will be available to the requestor indefinitely via encrypted e-mail service.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Sep 2026, 8 months.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 8 months is below that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: primary completion Dec 2026 → Sep 2026 and completion Dec 2026 → Sep 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 4, 2025
First posted
Dec 16, 2025
StartActual
Jan 5, 2026
Primary completionActual
Sep 28, 2026was Dec 2026
CompletionActual
Sep 28, 2026was Dec 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 13, 2026
Primary completion
Dec 30, 2026→Sep 28, 2026 (actual)
Oct 13, 2026
Study completion
Dec 30, 2026→Sep 28, 2026 (actual)
Oct 13, 2026
Enrollment
50 (estimated)→27 (actual)
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Recruiting→Completed
    Primary completion Dec 30, 2026→Sep 28, 2026 (now actual)
    Study completion Dec 30, 2026→Sep 28, 2026 (now actual)
    Enrollment 50 (estimated)→27 (actual)
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07283783
Collaborators
The Foundation for Barnes-Jewish Hospital
Responsible party
Sponsor
First posted
Dec 16, 2025
Start date
Jan 5, 2026
Primary completion
Sep 28, 2026
Completion
Sep 28, 2026
Last update
Oct 13, 2026

Study contacts

Joanna Abraham, Ph.D., FACMI, FAMIA
principal investigator · Washington University School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion